Semnur Pharmaceuticals Inc (OTCQB: SMNR) is a pharmaceutical company. The available filing excerpts from the 10-K filed 2026-02-27 (accession 000119312526082642) do not contain sufficient detail about Semnur Pharmaceuticals' core business activities, revenue model, products, customers, or competitive position to support a full canonical description. The filing excerpt primarily contains boilerplate SEC cover page language and references a domestication and business combination transaction, along with a transfer of securities from the Nasdaq Capital Market to the OTCQB marketplace under the symbols DNQAF, DNQWF, and DNQUF as of September 23, 2025. No product names, revenue figures, segment data, customer information, or operational details are present in the provided excerpts.

Source: SEC 10-K, filed 2026-02-27

Industry: Pharmaceutical Preparations